Climb Bio (CLYM) Change in Account Payables (2020 - 2026)

Climb Bio filings provide 7 years of Change in Account Payables readings, the most recent being -$1.4 million for Q1 2026.

  • Quarterly Change in Account Payables fell 2056.94% to -$1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $83000.0 through Mar 2026, up 109.11% year-over-year, with the annual reading at $1.6 million for FY2025, 262.41% up from the prior year.
  • Change in Account Payables hit -$1.4 million in Q1 2026 for Climb Bio, down from $1.8 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.8 million in Q4 2025 and bottomed at -$1.4 million in Q1 2026.
  • Average Change in Account Payables over 5 years is -$126294.1, with a median of $14000.0 recorded in 2023.
  • The largest annual shift saw Change in Account Payables soared 608.7% in 2022 before it tumbled 8528.57% in 2024.
  • Climb Bio's Change in Account Payables stood at -$744000.0 in 2022, then rose by 9.68% to -$672000.0 in 2023, then surged by 161.61% to $414000.0 in 2024, then soared by 332.85% to $1.8 million in 2025, then plummeted by 178.63% to -$1.4 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Change in Account Payables are -$1.4 million (Q1 2026), $1.8 million (Q4 2025), and -$393000.0 (Q3 2025).